Furthermore mAb 4C5 was shown to inhibit the extracellular interaction between HSP90 and the growth factor receptor ErbB-2 in MDA-MB-453 breast cancer cells, leading to impaired downstream signalling and reduced cancer cell motility and invasion [21]. Here, HSP90AA1 is linked to breast carcinoma.